(MENAFN- Navistrat Analytics) October 17, 2025- The rising incidence of chronic diseases is a major factor driving revenue growth in the vein illuminator market. According to projections by the World Health Organization (WHO), approximately 254 million individuals were living with chronic hepatitis B infection in 2022, with about 1.2 million new cases reported annually. The infection is primarily transmitted through contact with infected blood or bodily fluids—often via unprotected sexual contact, unsafe injections, or contaminated medical instruments. As of 2022, only 13% of affected individuals were aware of their infection, and just 3% (around 7 million people) were receiving treatment.

In December 2023, Polymatech Electronics introduced a new medical innovation—the vein detection light. This device aims to address the persistent challenge of precise vein identification in medical procedures. Featuring high-definition vein recognition and real-time full HD (1920 × 1080) visualization, it enables clinicians to accurately locate subdermal veins, potentially revolutionizing patient care, and procedural efficiency.

However, ensuring accuracy and reliability remains a critical challenge for vein imaging technologies. Although designed to simplify vein detection, the performance of these devices can be affected by factors such as skin pigmentation, moisture levels, and ambient lighting conditions, occasionally leading to inconsistent or inaccurate readings. Additionally, the high cost and limited accessibility of these systems pose barriers to widespread adoption. While such technologies can enhance patient safety and reduce the need for invasive procedures, their expense may restrict use among smaller or resource-limited healthcare facilities.

Segments market overview and growth Insights
Based on the type, the vein illuminator market is segmented into the handheld devices, tabletop devices, and wearable devices. Handheld devices segment contributed the largest share in 2024. Handheld vein illuminators have become vital instruments in modern medical diagnostics, enabling healthcare professionals to quickly and accurately evaluate clinical samples. These advanced devices support disease detection, condition monitoring, and treatment planning, and are widely used across hospitals, laboratories, and research centers. They encompass a variety of tools designed to conduct precise analyses on tissues, bodily fluids, and other biological specimens.

Regional market overview and growth insights
North America held the largest market share in the Vein Illuminator market in 2024. Market growth is primarily fueled by the increasing prevalence of chronic diseases and technological advancements in medical imaging. According to the Centers for Disease Control and Prevention (CDC), gestational diabetes—a condition that develops during pregnancy in women without preexisting diabetes—affects between 5% and 9% of pregnancies in the United States each year.

Competitive Landscape and Key Competitors
The Vein Illuminator market is characterized by a fragmented structure, with many competitors holding a significant share of the market. List of major players included in the Vein Illuminator market report are:

o AccuVein, Inc.
o Infinium Medical
o Christie Medical Holdings, Inc.
o NextVein LLC
o ZD Medical Inc.
o Hellovein
o Promed Technology Co., Limited
o BLZ Technology Inc.
o TransLite LLC
o Aimvein
o MAJUTECH Inc.
o iiSM Inc.
o Vivolight
o VNG Medical Innovation System Pvt Ltd
o BIOBASE GROUP

Major strategic developments by leading competitors
Veinlite: In June 2024, Veinlite, a pioneer in transillumination technology for vein visualization and access, introduced the upgraded EMS PRO device. This new model reinforces the company’s leadership in enhancing patient outcomes and reducing healthcare costs. Clinical studies have demonstrated that Veinlite devices outperform conventional care methods and near-infrared systems, resulting in higher success rates and greater patient satisfaction.

NextVein: In December 2022, NextVein, a leading provider of vein imaging solutions, announced the extension of its wheeled-stand promotion through February 2023. The NextVein vein finder utilizes infrared light to quickly and clearly display a patient’s veins, simplifying intravenous (IV) insertions, blood draws, and other medical procedures for healthcare professionals.

Navistrat Analytics has segmented the Vein Illuminator market based on type, technology, application, end-use, distribution channel, and region:
• Type Outlook (Revenue, USD Million; 2022-2032)
o Handheld Devices
o Tabletop Devices
o Wearable Devices

• Technology Outlook (Revenue, USD Million; 2022-2032)
o Transillumination
o Near-Infrared - NIR
o Ultrasound
o Others

• Application Outlook (Revenue, USD Million; 2022-2032)
o Blood Draw & Venipuncture
o Intravenous Access
o Cosmetic Procedures
o Oncology Treatments
o Others

• End-Use Outlook (Revenue, USD Million; 2022-2032)
o Hospitals
o Blood Donation Centers & Blood Banks
o Diagnostic Laboratories
o Ambulatory Surgical Centers (ASCs)
o Home Healthcare Settings
o Military & Emergency Medical Services (EMS)

• Distribution Channel Outlook (Revenue, USD Million; 2022-2032)
o Direct Sales
o Online Sales

• Regional Outlook (Revenue, USD Million; 2022-2032)
o North America
a. U.S.
b. Canada
c. Mexico

o Europe
a. Germany
b. France
c. U.K.
d. Italy
e. Spain
f. Benelux
g. Nordic Countries
h. Rest of Europe

o Asia Pacific
a. China
b. India
c. Japan
d. South Korea
e. Oceania
f. ASEAN Countries
g. Rest of APAC

o Latin America
a. Brazil
b. Rest of LATAM

o Middle East & Africa
a. GCC Countries
b. South Africa
c. Israel
d. Turkey
e. Rest of MEA

@Navistrat Analytics

MENAFN19102025008152017457ID1110215886